MENU
CRBU
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Caribou Biosciences (CRBU) Ownership - Who owns Caribou Biosciences?
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies... Show more
Profile
Industry
N/A
Address
2929 7th Street
Phone
+1 510 982-6030
Employees
158
Web
https://www.cariboubio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
71.99M
P/E Ratio
N/A
Total Cash
209.54M
Projected Growth
N/A
Total Debt
26.49M
Revenue
9.99M
Risk (Beta)
2.40
Dividend Yield
N/A
Total Cash/Share
2.25
Total Debt/Equity
N/A
Revenue/Share
0.11 USD as % of share price
Fundamentals
CRBU
Capitalization
72M
P/E Ratio
N/A
Risk (Beta)
2.40
Dividend Yield
N/A
Total Cash
210M
Total Cash/Share
2.25
Total Debt
26.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.11%
Revenue
9.99M
ROE
N/A
Book Value
253M
P/B Ratio
0.28
Cash Flow
N/A
Earnings
-1.65
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9K
Current Ratio
7.16
Current Revenue Per Employee
14129.25
Dividends Per Share - Security
N/A
EBITDA
-162.69M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-40.00
Shares Held By Institutions
116M
Shares Outstanding - Current
93M
Total Liabilities
60.4M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-51.321
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2929 7th Street
Phone
+1 510 982-6030
Employees
158
Web
https://www.cariboubio.com